Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to sign a consent form and are able to follow all the steps required by the study.
- You are male and at least 18 years old.
- You have never had a prostate biopsy before.
- You had a special type of MRI scan of your pelvis (called an mpMRI) within the last 90 days to check for possible prostate cancer.
- You are already scheduled to have a targeted biopsy procedure that uses MRI and ultrasound images together.
- Your MRI scan showed certain findings rated as PIRADS 2 or PIRADS 3 (a scoring system used by radiologists to describe areas of possible concern in the prostate — confirm with trial site if unsure what your score is).
Who may not be able to join:
- You have already been diagnosed with prostate cancer.
- You have a medical condition or situation that, in the doctor's judgment, could affect the study results or make it hard for you to complete the study (confirm with trial site).
- You have taken part in another interventional clinical trial in the last 30 days.
- You have a known allergy or sensitivity to the ingredients in a specific imaging drug called flotufolastat F 18, used in a PET-CT scan (confirm with trial site if you are unsure about your allergies).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 904-244-7340
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in positive predictive value (PPV); Change in negative predictive value (NPV); Improvement in Accuracy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.